Arthur J. Gallagher & Co. (NYSE: AJG) — Priced Above Marsh and Aon, Earning Half Their Return on Capital

Independent Equity Research Report date: 2026-08-15 · Price reference: ~$251.21 (2026-08-14 close) · Diluted market cap ~$65.0B · EV ~$77.2B An update to my prior report on this company dated 2026-06-14 (price reference ~$218.69)

⚡ Claude’s Take

This block is my own independent opinion. It is general information, not investment advice, and it is not a recommendation to buy or sell any security. The analysis that follows this block deliberately carries no recommendation and no price target — that discipline is reasserted there in full.

Verdict: HOLD — downgraded from BUY / accumulate-on-weakness two months ago. The thesis was right, the stock delivered, and the discount has been collected. Conviction: high on the business, medium on the call. Directional valuation zone: base-case fair value of roughly $255–290 (≈19–22x consensus FY2026 adjusted EPS of ~$13.23, or ~17–19.5x FY2027E of ~$14.80), with genuine accumulation interest only back below ~$230 (~17.4x FY2026E), a bear zone of ~$205–225 if the fourth-quarter organic step-up fails to arrive, and bull-case optionality to $330–370 on FY2027 earnings if the newly quantified AI margin programme starts showing up in reported numbers. At ~$251 the stock sits at the very bottom of the base zone. That is a fair price, not a bargain.

The one-line tag: “Every bear test failed — and the multiple noticed.” The June report set an explicit falsification test for the bear case: if adjusted EPS compounds at low double digits, organic holds at or above 5%, AssuredPartners synergies are raised again, and management executes buybacks while de-levering, the “deserved permanent discount” thesis is falsified. Three of those four conditions were met emphatically in a single quarter. First-half adjusted EPS rose 21.0% to $7.31; brokerage organic held 5% while Brown & Brown — the most rate-leveraged middle-market peer — printed minus 0.7%; the AssuredPartners synergy target was raised again, from up to $300M to up to $325M by early 2028, the second increase since announcement; and Gallagher repurchased $480M of stock in the first half against zero in all of 2024 and 2025, shrinking the share count for the first time in the modern era. Gallagher Bassett accelerated from 10% to 12% organic with margins up 140bps. Tuck-in multiples fell to roughly 9x for US retail and benefits while the CEO said flatly that “the days of 15, 16… times EBITDA are over” and “we are not in the business of diluting our shareholders.” The compounding machine is not merely intact; on the operating evidence it is running better than it was in June. The stock is up 14.9% since the prior report and 32% off the May low.

What stops this being a hold-and-add is arithmetic, not narrative, and it comes in three parts. First, the return on capital is still going the wrong way. On ROIC.ai’s consistent GAAP computation, Gallagher’s trailing return on invested capital has fallen from 7.26% a year ago to 5.63%, and return on equity from 9.50% to 6.72%. Over the same period and from the same vendor, Marsh McLennan earns 12.0% and Aon ~14.0%. Even generously normalised for non-cash amortisation — using consensus adjusted earnings plus after-tax interest over the full capital base — Gallagher gets to roughly 11%, still below both peers’ unadjusted figures. Second, and this is the finding that moves the call: Gallagher now trades at a premium to both of them on the only capital-structure-neutral measure. At $251.21 the enterprise value is ~$77.2B against trailing EBITDA of $3,966M — ~19.5x, or ~18.4x normalising for the fact that AssuredPartners has been owned for only ten and a half of the trailing twelve months — versus Aon at ~16.4x and Marsh at ~15.9x. The forward P/E parity with Aon (19.0x versus 18.6x) is an illusion produced by Gallagher’s higher leverage: net debt of $12.2B is ~3.1x trailing EBITDA against Aon’s 2.51x, and debt mechanically depresses P/E relative to EV/EBITDA. Paying two to three turns more for the asset that earns 5.6% on capital than for the ones that earn 12–14% requires the growth differential to be very large and very durable. It is one point of organic growth. Third, the fourth quarter has to deliver a step-up nobody has seen yet. First-half brokerage organic computes to ~4.6% and the third-quarter guide is 5%, so the 5.5% full-year figure requires roughly 7% in the fourth quarter. Wells Fargo’s analyst pressed exactly this on the call; the CFO attributed it to property-renewal seasonality and conceded “it would say that we’d have a little bit of a step up.” Consensus FY2026 adjusted EPS of $13.23 embeds the same shape — 27% second-half growth against 21% delivered in the first half. Both the guide and the estimate are back-end loaded into a quarter that has not happened.

The framing has changed from contrarian value-in-quality to quality-at-fair-value with an unhedged narrative beta to artificial intelligence — and that last clause is the part investors are underwriting without pricing. In the space of six months this stock was repriced twice on AI, in opposite directions, with no change whatsoever in its economics. On 9 February 2026 it fell 9.9% in a session — and the broker complex lost ~18% over six days — after OpenAI added insurance-native apps to the ChatGPT App Library, letting users compare and buy policies through AI. On 28 July 2026 the same complex rallied 4.3% to a nine-month high as capital fled AI capex names into defensives. Neither move was numerical. Meanwhile Gallagher’s own AI disclosure argues the opposite of the February panic: the CFO quantified savings of ~5% of production-layer cost, 10–15% of support, 20–30% of back office — arithmetic worth “600 basis points of margin expansion,” of which he expects to harvest perhaps two-thirds, “maybe there’s 400 basis points there,” over three to five years and incremental to ordinary expansion. That is roughly $2 per share of unmodelled optionality — and it is the single best reason to hold rather than trim. It is also completely unproven. The factor engine is worth noting here: despite a 26% three-month move, Gallagher’s momentum loading is still negative in every model and its beta is 0.22. This is a valuation recovery in an out-of-favour low-volatility name, not a crowded trend trade — which is why the correct response is to hold, not to sell.

Conviction and triggers. Conviction: high on the business, medium on the call — this is now a consensus long, with Piper Sandler upgrading to Overweight and price targets marched from the $225–275 range to $276–310 since June. What would flip me back to buy: the fourth quarter actually printing ~7% brokerage organic and the first visible evidence of AI savings landing above the 40–60bps baseline and a buyback funded from free cash flow rather than the revolver — or simply the price back below ~$230. What would flip me bearish: brokerage organic breaking below 4.5% with a full-year guide cut, net leverage pushed above ~3.25x trailing EBITDA to sustain repurchases, a return to large equity-funded top-of-cycle M&A, or genuine evidence of AI disintermediation in commercial placement rather than a personal-lines comparison app. One quieter signal deserves stating plainly: the company bought $480M of its own stock while describing it as undervalued, and not one insider bought a share on the open market — the Chief Accounting Officer instead sold 3,000 shares at $206 on 2 June, ten trading days from the multi-year low.

📈 Stock Price Action — Five-Year Event Map

Over five years Gallagher went from $132.94 (June 2021) to an all-time high of $346.63 (3 June 2025) — a 2.6x run on the hardest property-casualty pricing market in two decades — then gave back 45% to a low of $190.12 on 13 May 2026, and has since recovered 32% to $251.21 (14 August 2026). It trades ~27.5% below the five-year high, inside a 52-week range of $190.12–$310.73, and — for the first time in more than a year — above its 21-day ($250.69), 50-day ($241.32) and 200-day ($240.43) exponential moving averages. Price moves below are Fact; the attributed drivers are Interpretation.

The cycle narrative. (1) The 2021–2024 advance is the cleanest possible illustration of what a hard market does to a broker: commissions scale with premium, premium scaled with rate, and Gallagher compounded adjusted EBITDAC at double digits for twenty-plus consecutive quarters while its multiple expanded. (2) The December 2024 wobble was mechanical — issuing 30.4M shares at $280 to fund the largest broker acquisition in history is a 12% instant dilution, and the market marked it. (3) The move to the June 2025 all-time high was the last of the hard-market earnings, helped by an accounting quirk the June report dissected: Gallagher earned ~$363M of interest on the AssuredPartners financing proceeds while they sat in cash, flattering FY2025 brokerage margins by roughly 300bps. (4) The subsequent 29% decline was the reckoning — organic decelerated, the deal closed and the goodwill and share count arrived together, and GAAP EPS fell to $5.74 even as adjusted EPS rose. (5) and (6) were exogenous narrative shocks; the February AI event is the most instructive datum in this table, because a personal-lines policy-comparison app in ChatGPT has close to no bearing on a middle-market commercial and reinsurance broker, yet it removed roughly $6B of Gallagher’s market value in a session. (7) took the stock to $190.12, a 45% drawdown. (8) is the recovery this update documents: the 17 June investor meeting raised the 2026 outlook on brokerage margins and AssuredPartners synergies, which detonated a wave of price-target increases (Piper Sandler upgraded to Overweight, $225 → $276; UBS $250 → $291; Barclays $275 → $292; Wells Fargo $271 → $299), and then on 28 July the broker complex rallied 4.3% as investors rotated from AI capex exposure into defensives. (9) The 30 July Q2 print was a genuine beat that the stock sold — shares gapped to $269.99 and closed at $256.46 — a classic exhaustion of a pre-print run rather than a rejection of the results.

Changes Since the Prior Report (2026-06-14)

This is an update, not fresh coverage. The durable scaffolding of the June report — industry structure, the four-source moat, the AssuredPartners transaction history, the Gallagher Way operating model — carries forward and is not re-derived. What follows is the diff.

The defining fact of the interval is that the June report’s bear-case falsification test was comprehensively triggered, and the stock re-rated to reflect it. The prior report argued the de-rating overshot the change in the business; over the following two months adjusted earnings accelerated, organic held, synergies were raised again, buybacks began, and the shares rose 14.9%. The thesis worked. The task of this update is therefore not to re-tell it but to mark the price — and to ask whether what is left is still attractive.

What is confirmed: the operating franchise, the integration of AssuredPartners, the discipline of the tuck-in machine, and the low sensitivity of Gallagher’s organic algorithm to the property cycle. What is falsified: the June bear case that AssuredPartners marked a permanent step-down in quality and that the market was correctly repricing a deteriorating business. What is unresolved and getting worse: the return on the invested-capital base. What is new: a large, quantified, entirely unproven AI margin option — and a valuation that no longer offers a margin of safety against any of it going wrong.

1. Executive Summary

Arthur J. Gallagher & Co. is the world’s third-largest insurance broker and the only major broker to own a third-party claims administrator of scale. It is a capital-light, recurring-fee intermediary that earns commissions and fees for placing risk without bearing underwriting exposure, operating in a barrier-protected oligopoly alongside Marsh McLennan, Aon, Willis Towers Watson and Brown & Brown. Client retention runs in the mid-90s percent, capital expenditure is roughly 1% of revenue, and the business has now delivered twenty-five consecutive quarters of double-digit adjusted EBITDAC growth.

Two months ago this report argued that a 34% drawdown had disconnected Gallagher’s price from its earnings — that the de-rating was driven by the transitory optics of a 16% share issuance, a wall of acquisition amortisation and a cyclical organic deceleration, while adjusted earnings never stopped compounding. That argument has been settled in its favour. The second quarter of 2026 delivered 24% total revenue growth, 6% combined organic (brokerage 5%, risk management 12%), first-half adjusted EPS up 21.0% to $7.31, a second increase in the AssuredPartners synergy target to as much as $325M by early 2028, 50bps of underlying brokerage margin expansion, and the first meaningful share repurchases in years — $480M in the first half, enough to shrink the share count. Over the same quarter Brown & Brown, the peer most exposed to the same property correction, reported organic growth of minus 0.7%. Gallagher’s algorithm absorbed a 10% decline in property renewal pricing and still grew, because rate now accounts for only about one point of a six-point organic build.

The investment question has therefore moved. It is no longer whether the business is good — it plainly is, and it is executing better than in June — but whether the price still compensates for the one thing the good news has not touched. On a consistent third-party computation, Gallagher’s trailing return on invested capital has fallen over the past year, from 7.26% to 5.63%, with return on equity down from 9.50% to 6.72%. Marsh McLennan, measured identically on the same date, earns 12.0%; Aon earns ~14.0%. Normalising generously for the non-cash amortisation that depresses Gallagher’s GAAP figures gets it to roughly 11% — still short of both. And Gallagher now trades at a premium to both on the capital-structure-neutral measure: enterprise value of ~$77.2B against trailing EBITDA of $3,966M is ~19.5x (~18.4x normalising for AssuredPartners’ partial-year presence), against Aon at ~16.4x and Marsh at ~15.9x. The apparent parity on forward P/E — 19.0x against Aon’s 18.6x — is an artifact of Gallagher carrying more leverage, not evidence of comparable value.

Two further cautions sit on top. The full-year organic guide of 5.5% for brokerage requires roughly 7% in the fourth quarter against ~4.6% delivered in the first half and 5% guided for the third; consensus FY2026 adjusted EPS of $13.23 embeds the same back-end loading. And the stock’s recent history demonstrates an uncomfortable sensitivity to a variable nobody can model: it fell 9.9% in a single session in February on an OpenAI product announcement and rallied with the broker complex in late July on a rotation away from AI. Gallagher’s own AI disclosure — the CFO’s quantification of roughly 400bps of harvestable margin expansion over three to five years, incremental to the ordinary 40–60bps — argues the technology is a tailwind, and it is the most interesting new fact in this update. It is also entirely unproven and not in any published estimate.

This report takes no position and sets no price target (the single exception is Claude’s Take, above). It frames valuation strictly as embedded expectations and scenarios.

Section verdicts at a glance: Industry — structurally attractive, the property correction deepening but demonstrably absorbable. Competitive position — durable and, on this quarter’s relative evidence, strengthening; the gap to rate-leveraged peers widened materially. Growth — high quality, holding, but with an unproven fourth-quarter step-up embedded in the guide. Financial quality — excellent operating economics and a cash-conversion recovery, against a return on invested capital that continues to deteriorate. Capital allocation — genuinely improved: falling entry multiples, a real buyback, a raised synergy target; but the repurchase is debt-funded and the incentive design is unchanged. Changes/headwinds — net strongly positive on execution, net negative on price. Valuation — the discount has closed and inverted into a premium against better-returning peers.

2. Business Overview

The structural description in the June report stands; this section records what changed in the shape of the business.

Gallagher is an intermediary, not a risk-taker, operating through two reportable segments plus Corporate. It employs more than 73,000 people (up from ~72,000 at the prior report) across roughly 130 countries.

Brokerage (~89% of revenue before reimbursements) spans retail property/casualty, wholesale and specialty (including RPS and RT Specialty in US excess and surplus lines, and London Specialty in marine, aviation, energy and political violence), reinsurance broking through Gallagher Re, and employee benefits and HR consulting. The mix has shifted materially with AssuredPartners, which added roughly $2.4–2.9B of predominantly US middle-market retail revenue and closed on 18 August 2025. AssuredPartners contributed $222M of EBITA in the second quarter, in line with the June investor-day estimate, and is running at approximately 4% standalone organic growth — about a point below comparable Gallagher US businesses. Gallagher will begin reporting AssuredPartners inside organic growth from the fourth quarter of 2026.

Risk Management is Gallagher Bassett, and it is the most improved part of the business. Fee revenue grew 15.6% with 12% organic — accelerating from 10% in the first quarter — on new business and retention rather than rate, with adjusted EBITDAC margin up 140bps to 22.3% and full-year guidance now “north of 22%.” Management’s framing of the addressable market is worth recording as an indication of runway rather than as a forecast: of roughly $7 trillion of global premium, perhaps $4–5 trillion is non-life and non-health, around 60% of which converts to claims annually; Gallagher Bassett currently touches roughly $17–18B of claims payments. That is a very small share of a very large pool.

Revenue quality is unchanged and high. Commissions and fees renew annually on programmes that are re-bid infrequently; retention runs in the mid-90s percent; and fiduciary investment income is earned on client cash held in trust, which rose to $7,947M at 30 June 2026 from $7,142M at year-end. One accounting distortion dominates every year-over-year comparison in this update and must be held in mind throughout: in the first three quarters of 2025 Gallagher earned interest on the funds it was holding to buy AssuredPartners — $143M in Q1 2025, $144M in Q2 2025 ($0.42 per share), and $76M in Q3 2025 — which inflated 2025 brokerage revenue, EBITDAC and margins and is now reversing. This is why Q2 2026 brokerage adjusted EBITDAC margin fell optically to 33.3% from 36.1% while the underlying margin expanded 50bps. The distortion disappears from the fourth quarter of 2026.

The operating model — organic growth, M&A, productivity/quality, and culture — is unchanged in structure but has acquired a quantified third pillar. Where “productivity and quality” previously meant 40–60bps of annual margin expansion from workflow standardisation and offshoring, the CFO has now put numbers on the AI extension of that programme (see Financial Quality and Valuation below). Notably, he framed it as continuity rather than transformation: “never once over the last 20 years did we talk about that we were launching a programme to move work to lower cost locations… this is just cultural for us… it’s not something where we’re going to announce a huge transformation exercise.”

3. Industry Dynamics

The structural analysis in the June report carries forward: this is a barrier-protected oligopoly at the top, a capital-saturated roll-up market beneath it, and Gallagher uniquely straddles both. Three developments in the interval are material.

First, the property correction deepened, and the industry absorbed it. Gallagher’s second-quarter renewal premium changes were: property down 10% (versus down ~7% in the first quarter), casualty (general liability, commercial auto, umbrella) up 3%, professional lines including D&O and cyber up 1%, workers’ compensation up 2%, personal lines up 3%, package up 2%. Excluding property, renewal premium change was +3%. Management attributes the second-quarter deterioration partly to seasonal mix — the second quarter carries a heavier property renewal weighting than the fourth. Reinsurance property-catastrophe pricing moved lower again at the 6-1 renewals amid abundant capacity, while casualty reinsurance remained disciplined on US loss-cost trends.

The important observation is not that pricing fell but that the revenue did not. Gallagher grew brokerage organic at 5% and total organic at 6% into a 10% property decline. The CEO’s explanation is mechanically credible and worth quoting because it is testable: “premium changes in Gallagher’s revenues do not move one for one. As property pricing eases, many clients are opting in and using the savings to buy back coverage, increase limits, or improve structure after several years of opting out.” Management now sizes rate at approximately one point of the roughly six-point organic build, with new business, retention and exposure growth carrying the rest. That is a meaningful reduction from the 1–1.5 points cited a quarter earlier, and it is the single most important structural datum in this update: it converts “the cycle is turning against Gallagher” from a thesis risk into a manageable arithmetic headwind.

The CEO also drew a distinction between this soft market and its predecessors that is either genuine insight or convenient framing, and the evidence currently favours the former: “every other past soft market, the market has dropped like a brick across every line all at once. This is a property reset.” The line-by-line data supports him — casualty is firming on loss-cost trends, professional lines are stable, and only property is in retreat.

Second, the excess-and-surplus market is not giving business back. Historically a softening admitted market pulls risk out of E&S. Management states plainly that this is not happening: “we are just not seeing it flowing back into the admitted market the way it was in the past… the E&S market is not the market of last resorts anymore.” The driver is complexity rather than capacity — AI-related infrastructure and data centres, difficult liability risks, emerging specialty exposures. If correct, this is a structural change in the shape of the US property-casualty market that favours the wholesale intermediaries, and Gallagher owns two of the largest (RPS and RT Specialty).

Third, the capital cycle has begun to turn in Gallagher’s favour — the Marathon-lens caution in the June report has partially resolved on the buy side. Entry multiples for middle-market brokers are falling, not merely stabilising. Gallagher paid 9.4x in the first quarter and 11.3x in the second on a reported gross basis, with the CFO noting that US retail and benefits deals are being done “around nine times” and that the effective multiple net of unmodelled synergies is “clearly down below 11 times, 10 times.” The CEO was blunt about the seller-side psychology: consultants are telling private brokers that “if you’ve got a great firm, those multiples haven’t changed a bit… Hang tight. It ain’t happening. Multiples are coming down.” Gallagher’s own deal cadence is running at roughly 80% of its trailing ten-year average, which management characterises — plausibly — as sellers adjusting to the reset rather than Gallagher losing access.

This matters more than it may appear. The entire economic logic of Gallagher’s roll-up is buying private brokers below its own trading multiple. In June that arbitrage was under threat from both ends: private-equity bidders had pushed entry multiples to 10–15x while Gallagher’s own multiple had compressed to ~17x EV/EBITDA. Today entry multiples are ~9–11x and Gallagher’s own is ~19.5x. The spread has roughly doubled. For a company that closed 38 acquisitions in sixteen months, that is a larger economic event than a point of organic growth.

Regulation is unchanged as a thesis factor: licensing jurisdiction-by-jurisdiction, fiduciary handling of client funds, and the post-Spitzer conflict-of-interest regime function more as barriers to entry than as profit threats. One new regulatory-adjacent datum: the 27 January 2026 US government proposal for a 0.09% increase in 2027 Medicare Advantage payment rates triggered a sector-wide health-insurer selloff that took Gallagher down 5.1% in a session, a reminder that its benefits business carries a small but real policy beta.

Verdict: a structurally attractive industry in which the two cyclical forces are now pulling in opposite directions — and the net is favourable for Gallagher specifically. The revenue cycle is softening (property −10%, reinsurance down), which is a headwind. But the capital cycle has turned in the acquirer’s favour, restoring and widening the entry-multiple arbitrage that is the core economic engine of Gallagher’s model, and the E&S structural shift is durable. The industry verdict is upgraded modestly from the June report’s “structurally attractive, cyclically softening at the margin” — because the evidence now shows the softening being absorbed rather than merely asserted to be absorbable, and because the buy-side of the capital cycle has improved materially.

4. Competitive Position

The June report named four sources of advantage — customer captivity and switching costs, economies of scale in data and distribution, the tuck-in acquisition capability itself, and Gallagher Bassett as a unique asset. The quarter under review produced direct, quantitative evidence for three of the four, and it is the cleanest such evidence the franchise has generated in years.

The organic-growth cross-section is the proof. In the second quarter of 2026, with every major broker facing the same 10% property decline and the same softening reinsurance market:

(Sources: AJG Q2 2026 release and call; Aon, Marsh McLennan, Willis Towers Watson and Brown & Brown Q2 2026 results releases.)

The Brown & Brown comparison is the one that matters. Brown & Brown is the closest structural analogue to Gallagher’s middle-market retail book — similar client size, similar geographic weighting, similar property exposure — and it printed negative organic growth in the same quarter Gallagher printed 5%. That is a 5.7-point spread between two businesses facing an identical pricing environment. It is very difficult to explain that spread with anything other than execution: new-business win rates, retention, and the breadth of a portfolio that includes reinsurance, benefits, specialty and claims alongside retail property/casualty. The June report’s claim that Gallagher is a share-gaining operator within the oligopoly was an interpretation; after this quarter it is closer to a fact.

Gallagher Bassett is the strongest single piece of evidence for a differentiated asset. Twelve percent organic growth with a 140bp margin expansion, in a business with essentially no rate leverage, is not a cyclical outcome. Management’s account of the mechanism is specific enough to be credible: the substitution of “resolution managers” for adversarial claims adjusters, nurse case management with three points of contact, and — increasingly — machine learning applied to claim triage. The CEO’s illustration, which is an anecdote and must be treated as one, is that AI fraud detection saved a single client $100M on auditable numbers in medical fraud. The strategic claim underneath it is more interesting than the anecdote: that the insurance carriers themselves cannot match a specialist TPA’s vertical claims expertise, and that over the next decade some will stop trying. If even partially right, Gallagher Bassett’s addressable market expands structurally.

The acquisition capability has strengthened as a competitive advantage, not weakened. Being the acquirer of choice matters more when multiples are falling than when they are rising, because the constraint shifts from price to access. Gallagher is closing deals at ~9x for US retail and benefits while stating publicly that it will not chase; the CEO’s “we are not in the business of diluting our shareholders” is the most explicit statement of price discipline this management has made on a public call. The CFO added a genuinely competitive observation: that producers at private-equity-owned brokers may find “the dream of where they are… turning into a little bit of a nightmare,” creating a talent-acquisition channel independent of M&A.

Where Gallagher remains exposed — and one exposure got sharper. (1) The AI disintermediation question is no longer theoretical as a market variable, even if it remains theoretical as a business variable. February’s 9.9% single-session decline on an OpenAI product announcement demonstrated that a meaningful cohort of investors will sell brokers on evidence of consumer-facing AI placement, regardless of whether that evidence touches commercial middle-market risk. Gallagher’s own position — that AI amplifies advisory value and, per the CFO, “makes our professionals faster, better informed, and more productive, but they do not replace judgment, advocacy, relationships, or accountability” — is plausible and consistent with the margin programme it has quantified, but it remains unproven. (2) The scale and data advantage is shared with Marsh’s and Aon’s equivalent platforms; it protects the oligopoly, not Gallagher within it. (3) AssuredPartners is growing more slowly than the parent at ~4% organic against Gallagher’s 5% brokerage, which is a mild negative on the acquired asset’s quality even as its EBITA lands on plan.

Verdict: a durable, multi-source competitive advantage that strengthened measurably this quarter. The 5.7-point organic spread over the closest structural peer, Gallagher Bassett’s 12% organic with expanding margins, and an acquisition franchise buying at ~9x while competitors retreat are financial outcomes that would not exist without the moat — the Greenwald test passes cleanly. The honest qualifications are that the analytics advantage is shared with the other oligopolists, that the acquired AssuredPartners book grows a point slower than the parent, and that the AI question is now a live market risk even while the business evidence points the other way.

5. Growth History and Forward Opportunities

The record through the interval. Gallagher’s growth is holding at a level the June report treated as the base case rather than the bull case:

(Sources: AJG 10-Ks, Q1 and Q2 2026 releases and CFO Commentary, Q2 2026 call. Q1 2026 adjusted EPS derived as 1H $7.31 less Q2 $2.84. FY2026 consensus is a third-party estimate, not company guidance.)

The algorithm is working as designed. The 2026 build is roughly: one point of rate, plus new business, retention and exposure growth for the balance of six points of organic; plus 40–60bps of underlying brokerage margin expansion; plus a full year of AssuredPartners with rising synergies; plus a continuous tuck-in programme. That compounds to consensus adjusted EPS growth of ~23.8% in 2026 and ~11.9% in 2027 — the second figure being the better guide to the steady-state algorithm, since 2026 carries the AssuredPartners annualisation.

The one place the guide is exposed. First-half brokerage organic computes to approximately 4.6%. The third-quarter guide is 5%. The full-year guide is 5.5%. Arithmetic therefore requires roughly 7% in the fourth quarter. This was put to the CFO directly on the call by Wells Fargo’s Elyse Greenspan, and his answer was seasonality: “the second quarter is a little bit low because of the property renewals, that we are more impacted by property in the second quarter, that seasonality, and we won’t see that as much in the fourth quarter.” He added, candidly, “yes, it would say that we’d have a little bit of a step up in the fourth quarter relative to these numbers,” and characterised the published figures as midpoints of a ground-up divisional build with narrowing ranges as the year progresses. The seasonality explanation is internally consistent with the line-of-business detail — Gallagher also flagged 7-1 renewal concentrations in municipalities, pools and reciprocals, and complex fourth-quarter and 1 October placements. But it is an explanation, not a result. Consensus FY2026 adjusted EPS of $13.23 embeds the same shape: it implies roughly $5.92 of second-half adjusted EPS against $4.65 in the second half of 2025, or ~27% growth versus the 21.0% delivered in the first half. Both the organic guide and the earnings estimate are back-end loaded into a quarter that has not happened, and at 19.0x forward earnings there is no longer a valuation cushion under a miss.

Forward opportunities, updated. (1) AssuredPartners synergies — now targeted at $160M annualised by end-2026 and up to $325M by early 2028, raised from up to $300M in June and from $160M at announcement. The CFO attributed the increase to greater-than-modelled revenue synergies as the combined teams trade together, plus lower incremental cost because “our US chassis have the ability for all the investment we put into them over time to handle a substantial amount of additional revenue.” (2) The AI margin programme — the largest and least-priced opportunity, discussed under Financial Quality and Valuation below. (3) Wholesale consolidation from AssuredPartners — AssuredPartners previously spread wholesale placement across dozens or hundreds of intermediaries; routing an appropriate share to RPS and RT Specialty is worth, in the CFO’s estimate, “probably $100 million of opportunity” over three years, and he was careful to say it is “not meaningfully moving it right now.” (4) Complex specialty and E&S — data centres and AI infrastructure, construction, energy and infrastructure, which management explicitly cites as demand drivers. (5) War and political-violence repricing in London Specialty, where marine, aviation and conflict-zone exposures are seeing “significant repricing and more selective deployment of capacity.” (6) Gallagher Bassett, with a demonstrated 12% organic run-rate against a claims pool orders of magnitude larger than its current share. (7) The tuck-in runway, with ~$10B of estimated deployable capacity over two years and a pipeline of 30-plus term sheets representing ~$500M of annualised revenue.

Verdict: high-quality growth, holding better than the cycle would predict, with one unproven quarter embedded in the guide. The composition is good — new business, retention and exposure rather than rate — and the relative evidence against Brown & Brown is compelling. The Gallagher Bassett acceleration is genuine incremental quality. But the deceleration story is not over: brokerage organic of 5% in each of the first two quarters is the lowest paired reading in several years, AssuredPartners itself grows at only ~4%, and the fourth-quarter step-up is currently an assertion. The growth verdict is unchanged from June in substance — high quality, decelerating from a cyclical high, increasingly M&A-assisted — but the evidence behind it is materially stronger, and the guide now carries a specific, dateable risk.

6. Capital Allocation

This is where the most has changed, and the change is favourable — with one important qualification about how the change was financed.

The buyback is real, and the share count is finally shrinking. Gallagher repurchased 1.4M shares for $310M in the first quarter and 0.9M shares for $170M in the second — $480M in the first half, against zero in all of 2024 and all of 2025. Shares outstanding fell from 257.0M at 31 December 2025 to 256.3M at 30 June 2026. After a decade in which Gallagher was a structural net issuer — culminating in the ~35M shares issued at $280 to fund AssuredPartners, a ~16% increase in a single year — the sign has flipped. The magnitude is small (a net reduction of roughly 0.3%, since the repurchases had to absorb ~1.3M shares issued to benefit and option plans), but the direction is the thing the June report said would falsify the bear case, and it happened.

The qualification: it was funded with debt, not free cash flow. First-half operating cash flow was $967M against capital expenditure of $87M, for free cash flow of roughly $880M. Against that, Gallagher spent $616M on acquisitions, $206M on earnout payments, $359M on dividends and $480M on repurchases — $1,661M of uses against $880M of free cash flow. The gap was bridged by borrowing: gross corporate and other debt rose from $13,099M to $13,732M, and the previously-undrawn revolving credit facility stood at $1,365M at quarter-end against $0 at year-end. Net debt rose from $11,574M to $12,223M over the half. Aon did the same thing in the same quarter, and it deserves the same treatment: a repurchase funded by incremental leverage is a financing decision, not a distribution of surplus cash, and it should not be credited as though free cash flow had grown to accommodate it. Gallagher’s de-levering, which the June report listed as a bull-case condition, has not happened — it has been deferred in favour of buying stock and companies.

Management’s own framing is appropriately modest and should be taken at face value. Asked directly whether investors should model a normalised repurchase run-rate, the CFO said: “I wouldn’t model much… Our acquisition pipeline’s pretty darn good right now… I wouldn’t model a ton of share repurchases, but we’ll certainly be opportunistic.” M&A remains the first call on capital. Investors expecting the Aon-style pivot to systematic capital return are extrapolating beyond what Gallagher has said.

The M&A engine is running at better prices than at any point in the last cycle. Reported tuck-in multiples were 9.4x in the first quarter and 11.3x in the second, gross of synergies Gallagher does not underwrite. Adjusting for those, the CFO put the effective figure “below 11 times, 10 times,” with US retail and benefits deals “around nine times” and wholesale a little higher. Against Gallagher’s own ~19.5x EV/EBITDA, that is an arbitrage of roughly ten turns — approximately double the spread available when the stock was at $190 and entry multiples were at 12–15x. The company completed 38 acquisitions since April 2025 (including AssuredPartners and Woodruff Sawyer), closed 6 in the second quarter and 14 in the first half per the earnings release, and carries a pipeline of 30-plus term sheets representing ~$500M of annualised revenue. Deal cadence is running at ~80% of the trailing ten-year average — which management attributes to sellers adjusting to the multiple reset rather than to a shortage of targets.

The AssuredPartners synergy target was raised for the second time. From $160M at announcement, to up to $300M by early 2028 at the time of the June report, to up to $325M by early 2028 as of the second-quarter CFO Commentary — with $160M of annualised run-rate still targeted by the end of 2026. The composition of the increase is the encouraging part: the CFO attributed it primarily to revenue synergies exceeding the original model, plus lower-than-expected incremental IT, real-estate and back-office cost. Revenue synergies are harder to fake than cost synergies and are the ones that indicate the acquired producers are actually selling Gallagher’s capabilities.

The cash-flow quality problem the June report flagged has resolved. Payments on acquisition earnouts in excess of original estimates — the item that dragged FY2025 operating cash flow — fell to $141M in the first half of 2026 from $480M in the first half of 2025. First-half operating cash flow more than doubled, from $448M to $967M. The June report characterised the 2025 drag as one-time rather than structural; that has been confirmed.

The tax shield remains a genuine and durable asset. Cash taxes run at approximately 10% of EBITA against a ~20% book rate, supported by $3.4B of future tax savings from clean-energy credits and tax-deductible intangible amortisation, including $628M of credits on the balance sheet. Asked whether investors should glide the cash rate up toward the book rate, the CFO argued the amortisation shield “will continue to refresh itself as we continue to do more M&A” and that Gallagher expects to be able to generate a further $100–200M of credits after the current stock depletes. This is a real, quantifiable component of owner earnings and one of the reasons adjusted earnings are a better proxy for cash generation here than at most acquisitive companies.

What has not changed, and should be restated. The incentive design is unchanged from the 2026 proxy reviewed in June: the annual bonus is gated on adjusted revenue growth multiplied by adjusted EBITDAC growth, with no return-on-capital, no return-on-equity and no relative-TSR metric anywhere. The partial guard remains the long-term equity award, 75% of which vests on three-year adjusted EBITDAC per share growth — a metric the proxy explicitly says was chosen “to encourage executive officers to be prudent in the use of common stock to finance our M&A activity.” Officer and director ownership remains token at ~1.4% of the company. And the insider record over the interval is uncomfortable: zero open-market purchases, one gift of 23,800 shares by the Chief Operating Officer, routine option settlements — and a sale of 3,000 shares at $206.00 by the Controller and Chief Accounting Officer on 2 June 2026, ten trading days after the stock’s multi-year low and shortly before a 32% advance. A company that repurchases $480M of its own stock while describing it as undervalued, and whose insiders buy none of it personally, is sending two different signals.

Verdict: materially improved capital allocation — the best two quarters of allocation in the company’s recent history — with one honest asterisk. The entry-multiple arbitrage has roughly doubled; the synergy target has been raised twice; buybacks have started and the share count is shrinking; and the earnout cash drag has cleared. On the June report’s own test, this is the bear case falsified. The asterisk is that the repurchase was financed with revolver borrowings rather than surplus cash, so de-levering has been deferred rather than achieved, and the governance architecture that made the June report cautious — a size-based bonus, no returns metric, negligible insider ownership — is entirely unchanged. Management is allocating capital well despite the incentive design, not because of it.

7. Financial Quality

Unit economics remain excellent and continue to improve with scale. Capital expenditure was $87M on first-half revenue of $8,761M — under 1%. Underlying brokerage margin expanded 50bps in the second quarter, with full-year guidance of 40–60bps reaffirmed. Risk Management’s adjusted EBITDAC margin rose 140bps to 22.3%, with full-year guidance “north of 22%” — a business that management describes as having “reached a good scale point,” where 50bps a year of expansion is achievable if 12% growth persists.

The single most important reading discipline in this update: normalise for AssuredPartners deal-float interest. Reported brokerage adjusted EBITDAC margin fell to 33.3% in the second quarter from 36.1% a year earlier. That is not deterioration. In the first three quarters of 2025 Gallagher earned interest on the ~$10B it was holding to buy AssuredPartners — $143M in Q1 2025, $144M ($0.42 per share) in Q2 2025, and $76M in Q3 2025 — which flowed straight through revenue and EBITDAC at a 100% margin. That income is gone. The CFO stated the arithmetic explicitly: removing the effect, “adjusted revenues, adjusted EBITAC, and adjusted EPS [were] each up over 30%” for the combined segments. The distortion recurs in the third quarter and disappears in the fourth. Any analysis that reads the reported margin decline as a business problem is reading an accounting artifact.

GAAP versus adjusted earnings — the gap widened, and will persist for a decade. In the second quarter GAAP diluted EPS fell to $1.25 from $1.40 while adjusted EPS rose to $2.84 from $2.30. The reconciling items are amortisation of acquired intangibles — $301M in the quarter against $180M a year earlier, and $579M in the first half against $390M — plus integration and restructuring costs and the change in estimated earnout payables. The 10-Q’s forward amortisation schedule shows the scale of the drag: $558M in the remaining 2026, $1,092M in 2027, $1,050M in 2028, $992M in 2029, $933M in 2030 and $5,587M thereafter. Gallagher will be reporting GAAP earnings materially below cash earnings for the next ten years.

Two things make the adjusted figure the honest lens rather than a promotional one. The amortisation is non-cash, and it is tax-deductible, which is why cash taxes run at ~10% of EBITA against a ~20% book rate. The honest caveat from the June report stands and should not be dropped: integration and restructuring add-backs are recurring for a perpetual acquirer. They are a genuine ongoing cost of the business model, and a fully conservative owner-earnings figure sits somewhat below the headline adjusted number.

Cash flow recovered sharply. First-half operating cash flow was $967M against $448M, with the improvement driven principally by the fall in excess earnout payments from $480M to $141M. Free cash flow of ~$880M for the half is consistent with the capital-light model. One presentational warning: the quarterly operating cash-flow figure is close to meaningless because of fiduciary and working-capital seasonality — the second quarter of 2026 shows $10M of operating cash flow, and the second quarter of 2025 shows negative $424M. The half-year and full-year figures are the only ones worth reading.

Balance sheet. At 30 June 2026 Gallagher carried gross corporate and other debt of $13,732M ($13,609M net of issuance costs) against cash of $1,386M, for net debt of ~$12.2B — up from $11.6B at year-end. Total equity was $23,747M. Goodwill stood at $23,026M and net amortisable intangibles at $10,212M, together $33,238M. Tangible common equity remains negative (ROIC.ai computes a TCE ratio of −19.6%, improved from −26.6% at year-end as retained earnings accumulate). Fiduciary assets and liabilities — a matched pass-through that nonetheless generates float income — rose to $37,183M, with fiduciary cash of $7,947M. Net debt is approximately 3.1x trailing EBITDA of $3,966M, or roughly 2.8x on an annualised 2026 run-rate; management’s adjusted-EBITDAC basis produces a lower figure but is not disclosed in the 10-Q, so the ratios here are derived and labelled as such. The maturity profile is long-dated and predominantly fixed-rate; $9,550M of the total is registered senior notes, and the company was in compliance with all financial covenants at the quarter end.

The return-on-capital problem is the section’s central finding, and it worsened. On ROIC.ai’s consistent trailing computation:

Measured on the same date and by the same vendor, Marsh McLennan earns a 12.01% return on invested capital and a 25.72% return on equity; Aon earns approximately 13.98% (same source, same period end). Gallagher earns 5.63%. The gap is not narrowing; it widened over the past four quarters as the AssuredPartners goodwill entered the denominator ahead of the earnings that will eventually justify it.

Three qualifications, offered because the comparison is unflattering enough to demand them. First, Gallagher’s GAAP earnings are suppressed more than its peers’ by recent-deal amortisation, and that amortisation is non-cash and tax-deductible. A cash-basis approximation — consensus FY2026 adjusted earnings of roughly $3.43B (at $13.23 on ~259M diluted shares) plus after-tax interest of roughly $0.53B, over invested capital of roughly $36.4B — produces a return of approximately 10.9%. That is a materially better number, and it is the fairer one. It is also still below both peers’ unadjusted figures, and both peers would rise on the same treatment. Second, the denominator will improve mechanically as AssuredPartners’ earnings annualise and the synergies land, so the trough is likely at or near hand. Third, the incremental return on capital is far better than the average: tuck-ins bought at ~9x with synergies and multiple re-rating clear a high hurdle. The bull reading is that average ROIC is a backward-looking artifact of a large acquisition and incremental ROIC is what matters. The bear reading is that a company which has made 38 acquisitions in sixteen months is its incremental capital deployment, and the average is simply the accumulated record of it. Both readings are defensible; the data does not yet adjudicate between them.

The new item: a quantified AI margin programme. Asked when AI savings would be realised and whether they would be announced as a formal programme, the CFO gave the most specific disclosure of the interval: savings of approximately 5% of production-layer cost, 10–15% of support-layer cost, and 20–30% of back-office cost; arithmetic that “would produce 600 basis points of margin expansion”; an expectation of harvesting perhaps two-thirds of it — “maybe there’s 400 basis points there” — over three to five years; and, critically, that this is incremental to the 40–60bps of ordinary underlying expansion, not a component of it. On the brokerage revenue base, 400bps is worth roughly $560M of pre-tax EBITDAC, or — at Gallagher’s ~10% cash tax rate and ~259M diluted shares — approaching $2.00 per share, roughly 15% on top of FY2026E adjusted EPS. He was appropriately hedged (“I’d caution that maybe there’s going to be offsets”), grounded the credibility in prior investment (“we have already put in the cost effort to centralise and standardise our data and our processes… the cost for us to continue to implement AI is pretty small”), and explicitly declined to make it an announced transformation programme. It should be treated as a real option with meaningful expected value and very wide error bars — not as a line in a model.

Verdict: excellent operating economics and a decisively improved cash-flow picture, sitting on top of a return on invested capital that continues to deteriorate and is now less than half that of either large peer. The margin trajectory, the cash-conversion recovery, the tax shield and the capital-light model are all genuinely high quality, and the AI programme adds a large unpriced option. But the June report’s judgement that the ROIC caveat “does not fully resolve in the bull’s favour” has, if anything, been strengthened by another four quarters of data. This is a superb operating business that has paid a full price for a great deal of its scale, and the arithmetic of that has not yet reversed.

8. Changes and Headwinds — Last Two Years

The two-year record is dominated by AssuredPartners and its aftermath; the June report covered that ground and it is not re-derived. What follows emphasises the interval since.

1. The AssuredPartners integration has moved from “on plan” to “ahead of plan.” Nearly a year after closing (18 August 2025), retention is described as strong, second-quarter EBITA of $222M landed on the June investor-day estimate, and the synergy target has been raised for the second time to up to $325M by early 2028. The composition matters: the increase is driven more by revenue synergies than cost, which is the harder and more valuable kind. AssuredPartners will enter the organic-growth calculation from the fourth quarter of 2026, at a standalone run-rate of approximately 4%.

2. The pricing cycle deteriorated further, and Gallagher’s dependence on it fell. Property renewal pricing moved from −7% to −10%; reinsurance property-catastrophe pricing declined again at the mid-year renewals; and management now sizes rate at about one point of a six-point organic build, down from 1–1.5 points a quarter earlier. The offsetting dynamic — clients using premium savings to buy back limits and improve structure after years of trading down — is a genuine mitigant and is visible in the ex-property renewal figure of +3%.

3. The market repriced Gallagher twice on artificial intelligence, in opposite directions. On 9 February 2026 the shares fell 9.9% in a session to $217.76 after OpenAI added insurance-native applications to the ChatGPT App Library — integrations with Insurify and Tuio allowing users to compare and buy policies through AI — and the broker complex lost roughly 18% over the following six days on disintermediation fears. On 28 July 2026 a measure of insurance brokers rose as much as 4.3% to its highest intraday level since October as investors rotated out of AI capital-expenditure exposure and into defensives. Neither move reflected any change in Gallagher’s reported economics. This is the clearest evidence in the file that the stock now carries a substantial, unhedged narrative beta to a variable that has nothing to do with its financial statements.

4. The buyback started and the share count began to shrink — $480M in the first half against zero across 2024 and 2025, with shares outstanding down from 257.0M to 256.3M. Financed, as the capital-allocation section notes, with revolver borrowings rather than surplus cash.

5. The 17 June 2026 investor meeting reset expectations upward. Gallagher raised its 2026 outlook on brokerage margin expansion and AssuredPartners synergies, and expanded the AI narrative. The market reaction was substantial and sustained: the shares rose from $216.09 on 17 June to $252.44 by 2 July, and the sell-side moved with them — Piper Sandler upgraded to Overweight with a target raised from $225 to $276, UBS raised to $291 from $250, Barclays to $292 from $275, Wells Fargo to $299 from $271, KBW to $271 from $261, and Truist to $265 from $225.

6. The cash-flow drag cleared. Excess earnout payments fell from $480M (1H25) to $141M (1H26); first-half operating cash flow more than doubled to $967M.

7. Board change. Director David S. Johnson died, announced 29 July 2026. He had received a routine director stock award on 1 June 2026. No strategic implication; a board seat to fill. Executive leadership is otherwise unchanged: J. Patrick Gallagher Jr. as Chairman and CEO, Douglas Howell as CFO, with Thomas Gallagher and Patrick Murphy Gallagher in President and Chief Operating Officer roles.

8. Continued tuck-in activity at falling prices, including Cincinnati Benefit Solutions (June), Wilson M. Beck Insurance Services in Western Canada (July), Med James (July, wholesale and MGA), W.N. Tuscano Agency (July) and Apollo Insurance Solutions (August).

Verdict: net strongly positive on execution, net negative on price. Every operationally material development in the interval moved in the thesis’s favour — synergies raised, organic held against a worsening cycle, margins expanding underneath the float-income optics, cash flow recovered, buyback started. The genuine headwinds are the deepening property correction (largely absorbed), the deferral of de-levering, and a demonstrated vulnerability to AI-narrative repricing that cuts both ways. Nothing in the interval weakens the franchise. What weakened is the entry price.

9. Risk Analysis (Risk Matrix)

Net risk read. The risk profile has shifted since June in a specific way: the fundamental risks fell (AssuredPartners integration substantially de-risked, organic durability demonstrated against a worsening cycle, cash flow recovered) while the valuation and expectations risks rose (a premium multiple against better-returning peers, a back-end-loaded guide, a consensus that has flipped bullish). Gallagher’s risks remain overwhelmingly execution, capital-allocation and expectations risks rather than balance-sheet or existential ones — the capital-light, no-underwriting-risk model makes catastrophic loss remote. The two risks that now most plausibly move the stock are the fourth-quarter organic print and the AI narrative, and only one of them is under management’s control.

10. Valuation Discussion (Embedded Expectations)

Frame the multiple correctly. Gallagher’s trailing GAAP P/E of ~40.5x is a meaningless artifact of the $10.2B of remaining acquisition amortisation; the business must be valued on adjusted (cash) earnings, EV/EBITDA and free cash flow. The AZI own-history percentile reading illustrates why: the P/E percentile reads 76th precisely because GAAP EPS is distorted, while the P/B percentile reads 26.7th precisely because the December 2024 equity issuance and AssuredPartners goodwill inflated book value. The least-distorted of the three, price-to-sales, sits at the 65th percentile, and the composite at the 56th — the middle of Gallagher’s own multi-year range, and a decisive change from the low-end reading the June report relied upon.

(Sources: AZI price CSV and valuation_index; ROIC.ai enterprise value and valuation multiples; AJG Q2 2026 10-Q; third-party consensus adjusted EPS. Derived figures are shown as derived.)

The peer cross-section is the finding that matters. Measured on the same date, at the same closing prices, and — for the return figures — by the same vendor on the same basis:

Gallagher now trades at a two-to-three-turn EV/EBITDA premium to both large peers while earning less than half their return on invested capital. Normalising for AssuredPartners’ partial-year presence in trailing EBITDA narrows the premium from ~3.1 turns to ~2.0 turns against Aon and ~2.5 turns against Marsh, but does not remove it. And the apparent parity on forward P/E — 19.0x against Aon’s 18.6x — is not evidence of comparable value; it is the mechanical effect of leverage. Gallagher carries net debt of ~3.1x trailing EBITDA against Aon’s 2.51x, and debt shifts enterprise value away from equity, depressing P/E relative to EV/EBITDA. On the capital-structure-neutral measure, Gallagher is the most expensive of the three. This is the same correction that applies to Aon-versus-Marsh, run here in the opposite direction, and it is the single most important change in this update.

What Gallagher legitimately deserves for the premium. Three things, and they should be weighed honestly. (1) It grows one point faster — 6% combined organic against 5% at all three large peers, and the gap to the closest structural comparator, Brown & Brown, is 6.7 points. (2) It owns Gallagher Bassett, growing 12% organic with expanding margins and no meaningful rate leverage, which no peer of scale has. (3) It has a demonstrably larger and better-priced M&A runway, buying at ~9–11x against its own ~19.5x — an arbitrage roughly twice as wide as it was three months ago. Against those: it earns half the return on capital, carries the most leverage, has the least insider alignment, and its growth premium is one point.

Embedded expectations — what the buyer at $251 is underwriting. Decompose the prospective owner’s return with no change in multiple: approximately 5–6% organic growth; plus 40–60bps of underlying brokerage margin expansion, worth roughly 2 points of earnings growth at current margins; plus a tuck-in contribution of perhaps 3–4 points of revenue at accretive multiples; plus the residual AssuredPartners synergy ramp toward $325M; less the fiduciary-income normalisation; less minimal net share-count shrink at the demonstrated buyback pace; plus a ~1.1% dividend. That builds to roughly 11–13% prospective annual return with a static multiple — very close to what consensus already models, since FY2027 adjusted EPS of $14.80 represents 11.9% growth on FY2026’s $13.23. In other words, at 19.0x forward the market is now underwriting the historical low-double-digit per-share algorithm essentially in full. In June, at 16.5x on the same estimate, it was underwriting something closer to high-single-digit growth. The mispricing the June report identified has been paid out.

What remains unpriced is the AI margin option. If the CFO’s ~400bps of harvestable expansion arrives over three to five years, that is roughly $2.00 per share of incremental earnings on top of the algorithm — worth perhaps $35–45 of value at a 19x multiple, or 14–18% of the current price. Nothing in published consensus reflects it. That option is the strongest remaining argument for the shares, and it is genuinely a call option: unproven, unscheduled, and offered by management with explicit hedges.

Scenario analysis (illustrative, not targets; anchored on ~$13.23 FY2026E and ~$14.80 FY2027E adjusted EPS).

No price target. No recommendation. The above are scenarios bracketing embedded expectations, not a valuation call.

11. Variant Perception

Consensus belief — and how completely it has flipped. In June the sell-side was cutting: a string of price-target reductions and downgrades to Neutral on “softer organic growth,” AssuredPartners “bumpiness” and the soft cycle. Today it is raising in chorus. Since the prior report Piper Sandler upgraded to Overweight with a target moved from $225 to $276; UBS went to $291 from $250; Barclays to $292 from $275; Wells Fargo to $299 from $271; KBW to $271 from $261; Truist to $265 from $225; and at least one target reached $310 on 31 July. The implicit consensus is now: a high-quality, best-in-class-organic broker whose largest-ever acquisition is integrating ahead of plan, whose margins are expanding underneath a temporary optical distortion, and which has finally started returning capital — worth roughly 19–23x forward earnings. That is not a contrarian position. It is close to the position this report’s predecessor held two months ago, and the market has adopted it.

The strongest bull case. Gallagher is the best-executing operator in an excellent industry, and the evidence for that proposition strengthened materially this quarter: 6% combined organic against 5% at Marsh, Aon and Willis and minus 0.7% at Brown & Brown; Gallagher Bassett accelerating to 12% organic with margins up 140bps; 25 consecutive quarters of double-digit adjusted EBITDAC growth; underlying margin expanding 50bps while the reported figure fell on a lapping artifact; AssuredPartners synergies raised for the second time to $325M; and — the most underappreciated point — an acquisition arbitrage that has roughly doubled, with entry multiples down to ~9x for US retail while Gallagher’s own currency recovered to ~19.5x. On top of the compounding algorithm sits a quantified, unmodelled AI margin option worth perhaps $2.00 per share of earnings over three to five years. At 17.0x FY2027 earnings, an investor is paying a modest multiple for a business with a demonstrated low-double-digit per-share algorithm, a free option on AI, and a decade of tax-shielded cash earnings above GAAP.

The strongest bear case. Strip away the operating narrative and look at the capital. Gallagher earns a 5.63% return on invested capital and a 6.72% return on equity — less than half of Marsh’s 12.0% and Aon’s ~14.0%, measured identically — and those returns have fallen every quarter for a year. It has negative tangible book equity, $33.2B of goodwill and intangibles, the highest leverage of the three at ~3.1x, and a decade of amortisation ahead that will keep GAAP earnings a fraction of adjusted. For that profile the market now pays a premium on the only capital-structure-neutral multiple — ~19.5x EV/EBITDA against Aon’s 16.4x and Marsh’s 15.9x — in exchange for exactly one point of organic growth. The buyback that supposedly signals confidence was funded by drawing $1,365M on a revolver that had been undrawn at year-end, while net debt rose $649M in the half; and no insider bought a single share on the open market while the company was buying $480M of it, with the Chief Accounting Officer instead selling near the low. The full-year organic guide requires a ~7% fourth quarter that nobody has seen, and consensus earnings embed 27% second-half growth against 21% delivered. The bonus plan still pays for size with no returns metric anywhere, and insiders own 1.4%. On this reading the June discount was not a mispricing to be harvested but a risk premium that has now been sold too cheaply.

The 3–5 assumptions that matter most:

1. Does the fourth quarter deliver ~7% brokerage organic? (Bull: property seasonality is real and the divisional build has been accurate historically. Bear: it is an unproven step-up in a decelerating series, and the multiple no longer cushions a miss.) This is the nearest-dated, most falsifiable question in the file.
2. Does the return on invested capital inflect? (Bull: the trough is mechanical — AssuredPartners earnings annualise into a denominator already fully loaded, and incremental deals at 9x earn far above the average. Bear: four consecutive quarters of decline, and a company doing 38 deals in sixteen months is defined by its average, not its marginal, deployment.)
3. Is the EV/EBITDA premium to Aon and Marsh defensible? (Bull: one point of faster organic, a unique TPA growing 12%, and a doubled M&A arbitrage. Bear: half the return on capital and the most leverage; the premium is the entire remaining downside.)
4. Does the AI margin programme deliver? (Bull: ~400bps over 3–5 years, incremental to the baseline, worth ~$2.00 per share and in no published estimate. Bear: unscheduled, unaudited, hedged by its own author, and every peer will claim the same.)
5. Which direction does the AI narrative cut next? (Neither bull nor bear — a volatility factor. The same variable produced −9.9% in February and a sector rally in July.)

Factor-positioning read (the tape as evidence). The June report read the tape as “an abandoned low-volatility quality name possibly basing.” That read resolved in favour of the base, decisively. Over the three months to 14 August Gallagher returned approximately 26.0% (a 152% annualised figure in the FactorsToday leaderboard, de-annualised) with a Sharpe ratio of 4.53 and a maximum drawdown of only 7.9%; the six-month realised return is ~21.3% at a Sharpe of 1.45; and the one-year Sharpe has improved from −1.18 to −0.51. Six-month relative strength has flipped from deeply negative to +23.1, while twelve-month relative strength remains negative at −13.9 and the stock sits 27.0% below its peak. Realised beta is 0.22 and idiosyncratic volatility 21.2%.

The most useful detail is what the factor model still says Gallagher is. Despite a 26% three-month move, the Momentum loading remains negative in every model (−0.10 in the All-Factors model, −0.18 with sector and industry) because the twelve-minus-one-month window still spans the drawdown; the dominant loadings are Market (+0.56), Industry:Insurance (+0.53), Sector:Financials (+0.49) and LowVolatility (+0.45), against a negative BetaFactor loading (−0.40). Empirically this is still an out-of-favour, low-volatility, insurance-sector name undergoing a valuation recovery, not a crowded momentum trade — which argues against the reflex that a 32% move off the low means the trade is over-owned. It also means the positioning offers no protection: a name with 0.22 beta and negative momentum loading will not be carried higher by a market rally, and its 21% idiosyncratic volatility is doing most of the work.

Where consensus may be wrong now. The June variant perception — that the market was mistaking multiple compression for business deterioration — was correct and has been collected. The available variant perception today is narrower and points the other way: consensus is extrapolating an operating record that is genuinely excellent into a multiple that ignores the capital returns underneath it, and is paying a premium to two better-returning peers for one point of growth. The counter-risk to that variant view is straightforward and should be stated: if the AI margin programme delivers even half of what the CFO described, the ROIC gap closes from the numerator, the premium is retrospectively justified, and $251 will look cheap.

12. Fact vs. Interpretation Table

13. Open Questions

1. Will the fourth quarter deliver the ~7% brokerage organic the full-year guide requires? The single most dateable question in the file, and the one with the least cushion under it at 19.0x forward earnings.
2. When does return on invested capital inflect, and to what level? Four consecutive quarters of decline. The mechanical case for a trough is strong; the evidence for it is not yet visible.
3. Is the AI margin programme real at the scale described? ~400bps over 3–5 years, incremental to the baseline, with no announced programme, no milestones and no separate disclosure. What would the first visible evidence look like, and in which line?
4. How much of the AssuredPartners synergy raise is revenue versus cost? The CFO attributed the increase primarily to revenue synergies but gave no split. Revenue synergies are more valuable and less reversible; cost synergies are more certain.
5. What is AssuredPartners’ organic trajectory once it enters the reported figure in Q4 2026? Currently ~4%, about a point below comparable Gallagher businesses. Does it converge upward as the sales tools land, or does it drag the blended figure?
6. Will the buyback be sustained, and from what source of funds? The CFO said to model little. If it continues at the 1H pace it will require either free-cash-flow growth or further leverage; the first half used the latter.
7. Does the de-levering path still exist? Net debt rose in the half. Management has offered no explicit net-leverage target or timeline in the filings.
8. How durable is the ~10% cash tax rate? The CFO argues the amortisation shield refreshes with M&A and that a further $100–200M of credits can be generated. Both are plausible; neither is contracted.
9. Does the insider-purchase drought mean anything? Zero open-market buys across a 32% advance, alongside $480M of corporate repurchase. It may mean nothing; it is the kind of divergence worth tracking.
10. Which way does the AI narrative cut next, and does Gallagher’s own margin evidence eventually settle it? The February and July episodes suggest the market has no stable view, and neither does the evidence.

14. What Must Be True

For the bull case to be right:

• Brokerage organic reaches roughly 7% in the fourth quarter, validating the seasonality explanation and the 5.5% full-year guide, with FY2026 adjusted EPS landing at or above ~$13.23.
• The AI margin programme begins to show up in reported margin above the 40–60bps baseline within four to six quarters, at a pace consistent with ~400bps over three to five years.
• Return on invested capital troughs and inflects upward from 5.63% as AssuredPartners earnings annualise and synergies reach the $325M target, closing at least part of the gap to Marsh’s 12% and Aon’s 14%.
• Tuck-in entry multiples stay in the 9–11x range while Gallagher’s own multiple holds, preserving the widened arbitrage, and the buyback continues without pushing net leverage above ~3x.
• Falsification test: if, over the next four to six quarters, brokerage organic prints below 4.5% with a full-year guide cut, and reported underlying margin expansion fails to exceed the 40–60bps baseline in any quarter, and trailing ROIC remains at or below 6% — then the premium to Aon and Marsh is unjustified, the AI option is worthless, and the correct multiple is the peers’, not a premium to them.

For the bear case to be right:

• The fourth quarter misses, the full-year organic guide is cut, and consensus FY2026 adjusted EPS is revised below $13.
• Return on invested capital stays in the 5–6% range through 2027 as the goodwill base fails to earn its cost of capital, confirming that the roll-up’s average return — not its marginal deal economics — is the honest measure.
• The EV/EBITDA premium to Aon and Marsh compresses toward parity or a discount, on the recognition that one point of organic growth does not offset half the return on capital and the most leverage in the peer set.
• Leverage rises above ~3.25x trailing EBITDA to sustain buybacks and M&A, or Gallagher returns to large, equity-funded, top-of-cycle acquisitions.
• Falsification test: if, over the next four to six quarters, brokerage organic holds at or above 5.5% on a full-year basis, and trailing ROIC rises above 8%, and the AI programme delivers visible margin expansion beyond the baseline, and net debt falls while repurchases continue — then the return-on-capital critique was a transitional artifact of one large acquisition, the premium multiple was earned, and the bear case is dead.

15. Source Appendix

(See the separate Source Appendix file for the full list. Primary sources: AJG Form 10-Q for the period ended 2026-06-30 (filed 2026-08-05); AJG Q2 2026 earnings release and CFO Commentary (2026-07-30); AJG Q2 2026 earnings-call transcript (2026-07-30); AJG 8-Ks of 2026-06-17, 2026-07-29 and 2026-07-30; SEC Forms 4 filed June–August 2026; AJG FY2025 Form 10-K and 2026 DEF 14A as carried forward from the prior report. Third-party quantitative: ROIC.ai computed fundamentals, ratios, enterprise value and transcripts; AZI price history and valuation-percentile feed; FactorsToday factor-loading, leaderboard and stock-info endpoints. Prior work: my own AJG report of 2026-06-14 (baseline thesis) and companion reports on Aon, Willis Towers Watson and Brown & Brown (peer and industry cross-read). Public press and trade press for deal announcements, analyst actions and the February and July market events.)

APPENDIX A — Standard Diligence Questionnaire

Arthur J. Gallagher & Co. (NYSE: AJG) — as of 2026-08-15

Supplemental to the report above. Fact (F) / Interpretation (I) / Assumption (A) labelled where it matters. This is an update to the questionnaire of 2026-06-14; answers that have materially changed are marked [CHANGED].

General

What thoughtful questions have other investors asked about this company? The debate has moved substantially in two months. In June the recurring institutional questions were: did Gallagher overpay for AssuredPartners at the cycle top, is the organic deceleration cyclical or structural, and are the adjusted-EPS add-backs legitimate. Three of those have been answered in Gallagher’s favour by the second-quarter print — AssuredPartners is integrating ahead of plan with synergies raised twice, organic held at 5% while Brown & Brown went negative, and the earnout cash drag reversed. [CHANGED] The questions now being asked are different and harder: (1) Does the fourth quarter deliver the ~7% brokerage organic the 5.5% full-year guide requires, given ~4.6% in the first half and a 5% third-quarter guide? Wells Fargo’s analyst pressed this directly on the call. (2) Is the AI margin quantification — ~600bps gross, ~400bps harvestable over three to five years — real, and how would investors ever verify it absent a formal programme? Two analysts asked variants of this, including whether AI operating costs might “creep up over time.” (3) Should investors now model a normalised buyback run-rate, given $480M in the first half? (Raymond James asked; the CFO said “I wouldn’t model much.”) (4) With deal count at ~80% of the ten-year average, is the M&A engine slowing or is Gallagher exercising discipline? A fifth question that the market is asking but the sell-side largely is not: why does a company earning 5.6% on invested capital trade at a premium to peers earning 12–14%?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? (I) Mid-cycle on the rate component and rising on everything else. The property-casualty pricing cycle is past its peak and deteriorating — property renewal pricing was down 10% in the second quarter, worse than the ~7% of the first — but rate now contributes only about one point of a six-point organic build, down from 1–1.5 points a quarter earlier. Absolute earnings are rising sharply (first-half adjusted EPS +21.0%) on AssuredPartners annualisation, tuck-ins, margin expansion and Gallagher Bassett. One earnings component is unambiguously past its cyclical high and rolling off: deal-float interest income on the AssuredPartners financing proceeds ($143M in Q1 2025, $144M in Q2 2025, $76M in Q3 2025, nil thereafter). [CHANGED] The June answer described “decelerating off a cyclical pricing peak”; the second quarter demonstrated the deceleration being absorbed rather than merely asserted to be absorbable.

Driven by external environment or internal actions? (F/I) Increasingly internal, and this is now measurable. The cleanest evidence is the cross-section: facing an identical 10% property decline, Gallagher grew brokerage organic 5% while Brown & Brown — the closest structural comparator — printed minus 0.7%. A 5.7-point spread in the same pricing environment is an execution outcome. Management sizes the controllable components (new business, retention, exposure growth) at roughly five of the six points of organic growth.

How stable are revenues? (F) Very stable. Commissions and fees renew annually on programmes that are re-bid infrequently; retention runs in the mid-90s percent; benefits and reinsurance are substantially fee-based; and Gallagher Bassett’s claims-administration revenue has almost no rate leverage — it grew 12% organic in the second quarter. Gallagher bears no underwriting risk. Revenue has risen every year for more than a decade, and grew 24% in the most recent quarter.

Outlook for products/services? How big is the market — growing, shrinking, domestic or international? (F/I) Large and growing faster than GDP. Management sizes global premium at roughly $7 trillion, of which Gallagher touches $200–250B — approximately 3%. On the claims side, roughly $1.8 trillion of claims are paid annually against Gallagher Bassett’s ~$17–18B. Growth vectors: excess and surplus lines (where management states business is not flowing back to the admitted market despite the property reset — “the E&S market is not the market of last resorts anymore”), data centres and AI infrastructure, construction, energy, war and political-violence repricing in London Specialty, and the still-fragmented US middle market for acquisitions. Gallagher is global across ~130 countries but US-weighted; APAC and Specialty were called out as second-quarter outperformers.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? (I) Structurally, no change: the large-account and reinsurance tiers remain a closed oligopoly. Cyclically, less competitive for the acquirer — private-equity bidders have retreated as multiples reset, and Gallagher is now buying at ~9x for US retail and benefits against ~12–15x a year ago. The CEO’s account of seller psychology is that consultants are still telling private brokers to “hang tight” for the old multiples and “it ain’t happening.” [CHANGED] The June report carried a capital-cycle caution under the Marathon lens; the cycle has begun to turn in Gallagher’s favour on the buy side.

How profitable is the business (ROIC, ROE)? (F) This is the weakest part of the file and it deteriorated. On ROIC.ai’s consistent trailing computation, return on invested capital fell from 7.26% (Q2 2025) to 5.63% (Q2 2026), and return on equity from 9.50% to 6.72%. Measured identically on the same date, Marsh McLennan earns 12.01% ROIC and 25.72% ROE, and Aon approximately 13.98% ROIC. [CHANGED] (I) Two fair adjustments: Gallagher’s GAAP earnings are suppressed more than peers’ by recent-deal amortisation that is non-cash and tax-deductible, and a cash-basis approximation (consensus adjusted earnings plus after-tax interest over invested capital) produces roughly 10.9% — better, but still below both peers’ unadjusted figures. The operating business earns very high returns on tangible capital; the capital deployed to acquire it does not. [CHANGED] Note also a correction to the June report, which cited ROE of “~26–30%”: that described the pre-2025 capital structure, before the December 2024 equity issuance rebased equity from roughly $10B to roughly $23.7B. It no longer holds.

How profitable is the industry — how many competitors, what barriers to entry? (F/I) Highly profitable and tightly held. The global tier is five firms; reinsurance broking is effectively three (Guy Carpenter, Aon Reinsurance Solutions, Gallagher Re). Barriers are licensing across scores of jurisdictions, carrier relationships, specialty depth, global footprint and proprietary data. Gallagher’s EBITDA margin is ~25% at the consolidated level and ~33% underlying in brokerage; Marsh’s is ~25%. Capital intensity is negligible — capex under 1% of revenue.

Can the business be easily understood? (F) Yes at the operating level — an intermediary earning a percentage of premium plus fees, with no underwriting risk. No at the accounting level: the gap between GAAP diluted EPS ($1.25 in the quarter) and adjusted EPS ($2.84) requires understanding acquisition amortisation, integration costs and earnout remeasurement, and the year-over-year margin comparison requires normalising for $144M of one-time deal-float interest in the prior-year quarter. An investor who reads the headline GAAP numbers will reach the wrong conclusion in both directions.

Can it be undermined by foreign low-cost labour? (I) Gallagher is the one doing the offshoring, not the one being disrupted by it. Two decades of moving work to lower-cost centres of excellence is a stated source of the 40–60bps of annual margin expansion, and the CFO explicitly framed AI as the next iteration of that same programme rather than a new one. Client-facing broking is relationship- and licence-bound and is not offshorable.

Do brands matter? (I) Moderately, and less than the mechanism beneath the brand. The Gallagher name matters most in two places: as the acquirer of choice for selling brokers who value cultural fit over the highest private-equity bid, and in carrier relationships. For clients, the binding advantage is switching cost and specialist capability rather than brand.

What is the nature of competition? (F/I) Competition for producers, for acquisition targets and for accounts, in roughly that order of intensity. Notably the CFO argues the talent balance is shifting toward Gallagher as producers at private-equity-owned brokers find “the dream… turning into a little bit of a nightmare.” Gallagher also runs the largest internship programme it knows of — ~600 in the current cohort, with offers expected to 50–60% of seniors.

Customers’ switching costs? (F) High and evidenced by mid-90s-percent retention. Risk and benefits programmes are embedded, multi-year and re-bid infrequently; switching risks coverage gaps and the loss of institutional knowledge about a client’s risk profile. This is the primary moat and it passes the test that matters: strip it out and Gallagher earns sub-scale regional-broker economics rather than 33%+ underlying brokerage margins.

Financial Condition & Balance Sheet

Assets not fully recognised on the balance sheet? (I) Three. (1) The acquisition capability itself — twenty years, 750-plus deals, 38 in the last sixteen months — which is carried at nothing and is arguably the most valuable thing Gallagher owns. (2) The $3.4B of future tax savings from clean-energy credits and deductible intangible amortisation, of which $628M of credits sit on the balance sheet; this drives cash taxes to ~10% of EBITA against a ~20% book rate. (3) Client relationships beyond the amortising intangible, which is why retention runs in the mid-90s.

Off-balance-sheet liabilities? (F) Acquisition earnout payables (a recognised liability, but with cash timing that has historically surprised — $480M of payments in excess of original estimates in the first half of 2025, falling to $141M in the first half of 2026). Fiduciary assets and liabilities of $37,183M are matched and pass-through but represent client money held in trust, with $7,947M of fiduciary cash generating float income. Operating leases are capitalised ($578M of right-of-use assets). Letters of credit reduce revolver availability by roughly $180M.

How conservative is the accounting? (I) Generally clean, with four adjustments an investor must make. (1) Deal-float interest of $143M/$144M/$76M in the first three quarters of 2025 inflated prior-year revenue, EBITDAC and margins at a 100% margin and is now reversing; it is why Q2 brokerage margin fell optically to 33.3% from 36.1% while underlying margin expanded 50bps. The distortion ends in Q4 2026. (2) Acquisition amortisation of $301M in the quarter and $579M in the half is a genuine non-cash, tax-deductible add-back — but the remaining schedule ($558M in 2H26, $1,092M in 2027, $1,050M in 2028, $992M in 2029, $933M in 2030, $5,587M thereafter) means GAAP will understate cash earnings for a decade. (3) Integration and restructuring add-backs are recurring for a perpetual acquirer and are a real ongoing cost of the model; conservative owner earnings sit somewhat below headline adjusted EPS. (4) Quarterly operating cash flow is not meaningful because of fiduciary and working-capital seasonality — Q2 2026 shows $10M and Q2 2025 shows negative $424M. Only half-year and full-year cash flow should be read.

How CapEx-hungry is the business? (F) Not at all. Capital expenditure was $87M against first-half revenue of $8,761M — approximately 1%. The capital intensity of this business is in acquisitions, not fixed assets, which is precisely why the return-on-invested-capital question is the one that matters.

Capital Allocation & Management

How much FCF does the business generate, how does management use it, what is the philosophy? (F) First-half operating cash flow was $967M against $448M a year earlier, less $87M of capex, for free cash flow of approximately $880M. The priority stack is unchanged and explicit: M&A first, a steady but deliberately low dividend, opportunistic buybacks, continuous technology investment. Management estimates roughly $10B of deployable capacity over two years from cash on hand, free cash flow and investment-grade borrowings. [CHANGED] (F) First-half uses were $616M of acquisitions, $206M of earnouts, $359M of dividends and $480M of repurchases — $1,661M against $880M of free cash flow. The gap was financed: gross corporate debt rose from $13,099M to $13,732M and the revolver went from undrawn to $1,365M. Net debt rose from $11,574M to $12,223M. The buyback is a financing decision, not a distribution of surplus cash.

Significant acquisitions recently? (F) [CHANGED] Thirty-eight acquisitions since April 2025, including AssuredPartners ($13.45B, closed 18 August 2025) and Woodruff Sawyer ($1.2B, closed Q2 2025). In the current interval: 6 closed in Q2 and 14 in the first half per the earnings release, at reported gross multiples of 9.4x (Q1) and 11.3x (Q2) — approximately 9x for US retail and benefits, and below 10–11x net of synergies Gallagher does not underwrite. Named deals since the prior report include Cincinnati Benefit Solutions (June), Wilson M. Beck (July, Western Canada), Med James (July, wholesale/MGA), W.N. Tuscano (July) and Apollo Insurance Solutions (August). Pipeline: 30-plus term sheets representing ~$500M of annualised revenue. Deal cadence is running at ~80% of the trailing ten-year average.

Buying back shares? (F) [CHANGED — this is the largest single change since June.] Yes, for the first time at scale: 1.4M shares for $310M in Q1 and 0.9M shares for $170M in Q2 — $480M in the first half against zero in all of 2024 and all of 2025. Shares outstanding fell from 257.0M to 256.3M, the first net reduction of the modern era. (I) The magnitude is modest — a net ~0.3% after absorbing shares issued to benefit and option plans — and the CFO explicitly cautioned against extrapolation: “I wouldn’t model a ton of share repurchases, but we’ll certainly be opportunistic.” M&A remains the first call on capital.

Issuing large amounts of new shares to insiders? (F) No. Stock-based compensation is modest for a company of this size — $24M in the second quarter and $41M in the first half of non-cash compensation expense, against $8,761M of first-half revenue. The dilutive issuance in this business has historically been for acquisitions, not compensation.

Compensation policy of directors/management? (F) Unchanged from the 2026 proxy reviewed in June, and it remains the clearest governance weakness. The annual bonus is gated on adjusted revenue growth multiplied by adjusted EBITDAC growth — with no return-on-capital, no return-on-equity, no EPS and no relative-TSR metric anywhere. The partial guard is the long-term equity award, 75% of which vests on three-year adjusted EBITDAC per share growth, a metric the proxy says was chosen “to encourage executive officers to be prudent in the use of common stock to finance our M&A activity.” (I) For a company whose entire value proposition is disciplined capital deployment, and which is currently earning 5.6% on invested capital, the absence of any returns gate is a genuine flaw. Management has allocated capital well in this interval despite the incentive design.

Motivations of management? (I) Long-tenured, founder-family-led and evidently identified with the institution rather than with a stock price. Officer and director ownership is ~1.4% of the company, the CEO under 1% — so alignment rests on incentive design and reputation rather than economic exposure. [CHANGED] (F) The insider record over the interval is a datum worth stating: zero open-market purchases June–August 2026 while the company repurchased $480M and described the equity as undervalued; one gift of 23,800 shares by the Chief Operating Officer; routine option settlements; and a sale of 3,000 shares at $206.00 by the Controller and Chief Accounting Officer on 2 June 2026 — ten trading days after the multi-year low and shortly before a 32% advance. The corporate signal and the personal signal point in different directions.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? (F) No. Arthur J. Gallagher & Co. is a Delaware corporation listed on the NYSE, filing 10-Ks and 10-Qs, issuing a Form 1099-DIV. Common stock, no K-1, no partnership structure.

Dividend policy? (F) A steady, multi-decade riser held deliberately low as a residual after M&A. The quarterly dividend is $0.70 per share, declared again for the third quarter on 29 July 2026, for a yield of approximately 1.1% at $251.21. First-half dividends paid were $359M. This is not a return-of-capital vehicle and is not intended to be.

How profitable is the business? (F) Two answers that must be given together. Operationally: consolidated EBITDA margin ~25%, underlying brokerage adjusted EBITDAC margin ~33% and expanding 40–60bps a year, Risk Management 22.3% and expanding 140bps, capex under 1% of revenue, cash taxes ~10% of EBITA. On capital: return on invested capital 5.63% and return on equity 6.72%, both falling, against Marsh at 12.0%/25.7% and Aon at ~14.0%. The operating business is excellent; the returns on the capital assembled to build it are not.

Is net income diverging from cash from operations? (F) Yes, in the direction that favours the owner. First-half GAAP net earnings were $1,147M against operating cash flow of $967M — but that comparison understates the divergence because the first half absorbed a $949M build in accounts receivable and $206M of earnout payments. The structural divergence runs the other way: $697M of first-half depreciation and amortisation is non-cash, and the amortisation portion is tax-deductible, which is why cash taxes run at half the book rate. Cash earnings materially exceed GAAP earnings and will for a decade. The honest offset is that integration and restructuring costs added back to adjusted earnings are genuinely recurring for a perpetual acquirer.

Risks & Downside

What factors would cause the stock to decline? (I) In rough order of near-term probability: (1) a fourth quarter that fails to deliver the ~7% brokerage organic the 5.5% full-year guide requires — the single most dateable risk; (2) compression of the ~2–3-turn EV/EBITDA premium to Aon and Marsh as investors weigh a 5.6% return on capital against their 12–14%; (3) another AI-narrative shock of the February type, which removed ~9.9% in one session on a product announcement with no bearing on commercial placement; (4) a further leg down in property or a spread of the correction into casualty; (5) leverage rising above ~3.25x to sustain buybacks and M&A, or a return to large equity-funded top-of-cycle acquisitions; (6) failure of the AI margin programme to produce any visible evidence, which would remove the option value currently supporting the multiple.

Risk of a catastrophic loss? (I) Low. Gallagher bears no underwriting risk and holds no insurance liabilities. The plausible catastrophic scenarios are a large goodwill impairment on AssuredPartners (materially de-risked this quarter — EBITA on plan, synergies raised, retention strong) or a genuine technological disintermediation of commercial broking, which the current evidence does not support and Gallagher’s own margin programme argues against. Fiduciary funds are held in trust and matched by fiduciary liabilities; a fiduciary-handling failure would be a reputational and regulatory event rather than a solvency one.

Chance of a total loss? (I) Negligible. Capital-light, no underwriting risk, ~130 countries, dozens of lines of business, investment-grade rated, in compliance with all covenants at 30 June 2026, with long-dated predominantly fixed-rate debt of which $9,550M is registered senior notes. Total loss is not a realistic scenario for this business.

Recent News & Events

Has the business environment changed recently? (F) [CHANGED] Yes, in three ways. (1) The property correction deepened from ~−7% to −10% while Gallagher’s dependence on rate fell to about one point of six. (2) The capital cycle turned in Gallagher’s favour on the buy side — entry multiples fell to ~9x for US retail while Gallagher’s own multiple recovered to ~19.5x, roughly doubling the acquisition arbitrage. (3) The market’s view of artificial intelligence in insurance distribution reversed twice: on 9 February 2026 Gallagher fell 9.9% in a session after OpenAI added insurance-native applications to the ChatGPT App Library, and the broker complex lost ~18% over six days on disintermediation fears; on 28 July 2026 the same complex rallied as much as 4.3% to a nine-month high as capital rotated out of AI capital-expenditure exposure into defensives.

Significant acquisitions? (F) See Capital Allocation above. The material development is not a new large deal but the second raise of the AssuredPartners synergy target, to up to $325M by early 2028 from up to $300M in June and $160M at announcement, with $160M of annualised run-rate still targeted by the end of 2026. AssuredPartners contributed $222M of EBITA in the quarter, on plan, and is running at ~4% standalone organic growth; it enters the reported organic calculation from the fourth quarter of 2026.

Change in accounting policies? (F) None identified in the second-quarter 10-Q. The comparability issues in this update are economic (deal-float interest lapping, AssuredPartners partial-year presence in trailing metrics), not policy changes.

Recent changes — new markets, facilities, management? (F) No change to executive leadership: J. Patrick Gallagher Jr. remains Chairman and CEO, Douglas Howell CFO, with Thomas Gallagher as President and Patrick Murphy Gallagher as Chief Operating Officer. Headcount rose to more than 73,000 from ~72,000. Director David S. Johnson died, announced 29 July 2026, leaving a board vacancy; he had received a routine director stock award on 1 June 2026. Gallagher held its regularly scheduled investor meeting on 17 June 2026, at which it raised its 2026 outlook on brokerage margin expansion and AssuredPartners synergies and expanded its AI narrative — an event that preceded a 32% advance in the shares and a broad wave of sell-side price-target increases. Geographic expansion in the interval was through tuck-ins rather than new market entry, notably Wilson M. Beck in Western Canada.

APPENDIX B — Source Appendix

Arthur J. Gallagher & Co. (NYSE: AJG) — research update as of 2026-08-15

Every material number driving a verdict in this report has been reconciled to the Q2 2026 earnings release, the Form 10-Q, or the earnings-call transcript. Third-party aggregated data (ROIC.ai, AZI, FactorsToday) is not primary and is labelled as such. Prices and multiples are stated as of the 2026-08-14 close of $251.21 unless otherwise noted; derived figures — diluted market capitalisation ~$65.0B, enterprise value ~$77.2B, EV/EBITDA ~19.5x, forward P/E ~19.0x — are computed from the cited inputs and shown as derived.

A. Primary — SEC filings and company disclosures

B. Peer and industry sources

C. Third-party quantitative data (not primary; reconciled to filings where material)

D. Analytical frameworks

E. Coverage notes and limitations

• Scope. This is a follow-up to the report of 2026-06-14. The industry structure, moat mechanism, AssuredPartners transaction history and proxy/incentive analysis are carried forward from that report and were not re-derived; effort was directed at what changed.
• Effort allocation. Work was directed at the diff: the Q2 2026 print, the June investor meeting, the capital-allocation change, the valuation re-rate and the peer cross-section.
• Two reconciled discrepancies. (1) The earnings release states 6 acquisitions closed in the second quarter and 14 in the first half; the call says 7 tuck-ins in the quarter. The release is primary and is cited; the difference is immaterial. (2) Zacks reported prior-year Q2 adjusted EPS of $2.33 while the company’s release states $2.30; the release governs, making the growth rate +23.5% rather than +21.9%.
• One correction to the prior report. The June 2026 report characterised return on equity as “~26–30%.” That described the pre-2025 capital structure; following the December 2024 equity issuance, which rebased equity from roughly $10B to roughly $23.7B, trailing ROE on ROIC.ai’s GAAP computation is 6.72%. This report uses the current figures throughout.
• Derived ratios are labelled. Net leverage, normalised EV/EBITDA, the cash-basis ROIC approximation and the per-share value of the AI margin programme are all computed by the analyst from cited line items and are identified as derived, not as vendor outputs. Management does not disclose an adjusted-EBITDAC net-leverage ratio in the 10-Q.
• Authority. ROIC.ai, AZI and FactorsToday are third-party aggregated data and are not primary. Where a computed figure drives a verdict — the ROIC series, EV/EBITDA, the organic cross-section — the underlying line items or the primary disclosure are cited alongside it. For US filers, EDGAR and the 10-K/10-Q remain primary and govern any conflict.